Modulation of Free Corticotrophin-Releasing Hormone, Adrenal and Placental Steroid Hormone Levels Induced by Mifepristone during Pregnancy

Mifepristone is a progesterone receptor antagonist widely used in obstetrics. The aim of the study was to focus on free corticotrophin-releasing hormone (CRH) and also describe modulation of adrenal and placental steroid hormone concentrations induced by mifepristone. Methods: Twenty-six women were enrolled in the study. They received mifepristone for termination of pregnancy. Maternal blood samples were retrieved before administration of mifepristone (600 mg) and 48 h after, just before induction of labor. Bound and free CRH levels were determined in maternal blood concomitantly with cortisol, estriol, progesterone and SDHEA levels. Also paired fetal cord blood samples were collected. Results: Maternal plasmatic CRH level did not change after mifepristone absorption but free CRH increased significantly (0.500 ± 0.326 vs. 0.388 ± 0.303 ng/ml, p = 0.040). A significant decrease of progesterone was observed (83.6 ± 49.3 vs. 95.6 ± 54.9 ng/ml, p = 0.001) with a lower progesterone/estriol ratio (26.9 ± 15.7 vs. 40.7 ± 31.1, p = 0.004). There was a strong association between maternal and fetal free CRH (r2 = 0.675, p = 0.001), cortisol (r2 = 0.570, p = 0.019), and positive but modest correlation for progesterone (r2 = 0.341, p = 0.046) and estriol (r2 = 0.379, p = 0.025) levels. Conclusion: Mifepristone has an effect on free CRH level and changes the estriol-progesterone balance.

[1]  P. McElduff,et al.  Patterns of plasma corticotropin-releasing hormone, progesterone, estradiol, and estriol change and the onset of human labor. , 2009, The Journal of clinical endocrinology and metabolism.

[2]  T. Cheetham,et al.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is associated with a prolonged gestational age , 2007, Archives of Disease in Childhood.

[3]  Roger Smith,et al.  Corticotrophin releasing hormone and the timing of birth. , 2007, Frontiers in bioscience : a journal and virtual library.

[4]  Lu Gao,et al.  Corticotropin-releasing hormone inhibits progesterone production in cultured human placental trophoblasts. , 2006, Journal of molecular endocrinology.

[5]  T. Ochędalski,et al.  Maternal and fetal hypothalamo-pituitary-adrenal axis: different response depends upon the mode of parturition. , 2004, Neuro endocrinology letters.

[6]  D. Wing,et al.  Mifepristone: Effect on Plasma Corticotropin-Releasing Hormone, Adrenocorticotropic Hormone, and Cortisol in Term Pregnancy , 2004, Journal of Perinatology.

[7]  R. Gitau,et al.  Human fetal and maternal corticotrophin releasing hormone responses to acute stress , 2004, Archives of disease in childhood. Fetal and neonatal edition.

[8]  H. Zahradnik,et al.  Expression patterns of CRH, CRH receptors, and CRH binding protein in human gestational tissue at term. , 2003, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[9]  C. Hobel,et al.  Corticotrophin‐releasing Hormone and CRH‐binding Protein: Differences between Patients at Risk for Preterm Birth and Hypertension , 1999, Annals of the New York Academy of Sciences.

[10]  K. Karalis,et al.  Cortisol blockade of progesterone: A possible molecular mechanism involved in the initiation of human labor , 1996, Nature Medicine.

[11]  C. Wolfe,et al.  Corticotrophin-releasing hormone-binding protein in human fetal plasma. , 1995, The Journal of endocrinology.

[12]  W. Vale,et al.  Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancy. , 1993, The Journal of clinical endocrinology and metabolism.

[13]  I. Mackenzie,et al.  The placental transfer of mifepristone (RU 486) during the second trimester and its influence upon maternal and fetal steroid concentrations. , 1990, British journal of obstetrics and gynaecology.